What is the appropriate inpatient workup and management for anemia in a hospitalized patient?

Inpatient Anemia Workup and Management

Begin with a structured laboratory-based diagnostic approach using MCV classification, followed by targeted testing based on reticulocyte count and iron parameters, while implementing restrictive transfusion thresholds and phlebotomy reduction strategies to prevent worsening anemia during hospitalization. 1

Initial Diagnostic Framework

Define the Anemia

• Men: Hemoglobin < 13.0 g/dL
• Women: Hemoglobin < 12.0 g/dL 1

First-Line Laboratory Tests

Obtain reticulocyte count immediately to distinguish regenerative from non-regenerative anemia:

• Reticulocytes > 10 × 10⁹/L: Regenerative anemia → pursue hemolysis workup
• Reticulocytes ≤ 10 × 10⁹/L: Non-regenerative anemia → proceed to MCV classification 1

MCV-Based Diagnostic Algorithm

Microcytic Anemia (MCV < 80 fL)

Order iron profile workup:

• Ferritin
• Transferrin saturation (TSAT)
• Reticulocyte hemoglobin equivalent (RetHe) if available
• Percentage of hypochromic red cells

Iron deficiency criteria:

• Ferritin < 100 μg/L
• TSAT < 20%
• RetHe < 29 pg
• Hypochromic cells > 10% 1

If iron deficiency not confirmed, consider:

• Inflammatory anemia
• Mixed deficiencies
• Complementary workup as needed

Normocytic Anemia (MCV 80-100 fL)

Obtain:

• Creatinine (assess for renal failure)
• CRP (evaluate for inflammation)

Consider:

• Anemia of inflammation (most common in hospitalized patients)
• Chronic kidney disease
• Endocrine disorders
• Vitamin B6 deficiency 1

Macrocytic Anemia (MCV > 100 fL)

Order:

• TSH (and free T4 if abnormal)
• Folate level: deficiency defined as serum folate < 10 nmol/L (4.4 μg/L) or RBC folate < 305 nmol/L (< 140 μg/L)
• Vitamin B12: deficiency defined as < 150 pmol/L (< 203 ng/L)
  • Critical caveat: Normal B12 does not exclude deficiency; if clinical suspicion persists, obtain methylmalonic acid (> 271 nmol/L confirms B12 deficiency) 1

Consider:

• Hypothyroidism
• Myelodysplasia (may require bone marrow biopsy)

Transfusion Management

Restrictive Strategy is Standard

Use hemoglobin threshold < 70 g/L (7.0 g/dL) for transfusion in most hospitalized patients, including those with:

• ARDS
• Septic shock
• General critical illness 2, 3

Single-unit transfusion policy: Transfuse one unit at a time, then reassess 1

Important exception: Optimal thresholds remain uncertain in patients with acute coronary syndromes or active ischemic heart disease—clinical judgment required 2

This restrictive approach has been consistently associated with comparable or superior outcomes compared to liberal strategies, with the added benefit of reducing transfusion-related complications 4, 3

Pharmacologic Treatment

Iron Supplementation

Intravenous iron is preferred in hospitalized patients and can safely raise hemoglobin to clinically meaningful degrees 3, 5

Dosing regimens:

• 10-20 mg/kg/week IV, with maximum weekly doses of 600-1000 mg depending on formulation 5
• Oral iron (60-120 mg elemental iron daily) is less effective in acute hospital settings due to inflammation-induced hepcidin elevation 5

Avoid routine iron therapy except:

• Confirmed iron deficiency
• In conjunction with erythropoietin therapy 1

Erythropoietin Therapy

Consider erythropoietin-stimulating agents (ESAs) in select populations:

• Post-trauma patients (strong evidence for benefit) 1
• Moderate-to-severe anemia: 600 IU/kg/week IV or subcutaneously
• Critical settings: 300 IU/kg/day 5

Do NOT use routinely in general critical care patients due to:

• Uncertain thromboembolic risk
• Limited evidence of mortality benefit 1, 3

Vitamin Supplementation

For confirmed deficiencies:

• Vitamin B12 supplementation for documented deficiency
• Folic acid for documented deficiency 5

Prevention Strategies During Hospitalization

Phlebotomy Reduction

Implement blood conservation measures:

• Use small-volume blood collection tubes
• Employ closed blood-conservation systems
• Minimize unnecessary laboratory testing 1, 3

Rationale: Hemoglobin drops by mean 0.52 g/L per day during ICU stay, with iatrogenic blood loss being a major contributor 2, 6

Discharge Planning and Follow-Up

Critical Documentation Requirements

Discharge paperwork must include:

• Explicit documentation of anemia diagnosis
• Type of anemia (iron deficiency, inflammatory, etc.)
• Prescribed iron supplementation (if indicated)
• Follow-up plan with specific appointments 7

Common pitfall: Only 48.5% of patients receive appropriate discharge documentation for iron-deficiency anemia, leading to poor continuity of care 7

Outpatient Considerations

Inpatient anemia workup has demonstrated value:

• Associated with increased gastrointestinal cancer diagnosis (HR 1.53 for GI cancer, HR 1.23 for any cancer) 8
• Higher colonoscopy completion rates
• Lower anemia prevalence at 1-year follow-up 8

For patients who may benefit from early cancer diagnosis, hospitalization represents a valid opportunity to initiate evaluation rather than deferring entirely to outpatient setting 8

Special Populations

Chronic Kidney Disease

In CKD patients with anemia:

• More proactive IV iron supplementation thresholds, especially for hemodialysis patients 9, 10
• ESAs remain preferred first-line therapy over HIF-prolyl hydroxylase inhibitors due to cardiovascular safety concerns 9
• Individualize timing and type of treatment based on comprehensive evaluation 9

Inflammatory Anemia

Most common in hospitalized patients, characterized by:

• High hepcidin levels
• Low erythropoietin
• Iron-restricted erythropoiesis despite adequate iron stores 6

Management focuses on:

• Treating underlying condition
• Restrictive transfusion strategy
• Avoiding routine iron supplementation (ineffective due to hepcidin blockade) 6, 3